Use of adjuvant intralesional bevacizumab for aggressive respiratory papillomatosis in children. [electronic resource]
Producer: 20130718Description: 496-501 p. digitalISSN:- 2168-619X
- Adolescent
- Age Factors
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Bevacizumab
- Biopsy, Needle
- Chemotherapy, Adjuvant
- Child
- Child, Preschool
- Cohort Studies
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Follow-Up Studies
- Humans
- Infant
- Injections, Intralesional
- Laryngeal Neoplasms -- drug therapy
- Laryngoscopy -- methods
- Laser Therapy -- methods
- Male
- Neoplasm Invasiveness -- pathology
- Neoplasm Staging
- Papillomavirus Infections -- drug therapy
- Pilot Projects
- Prospective Studies
- Quality of Life
- Reoperation -- statistics & numerical data
- Respiratory Tract Infections -- drug therapy
- Risk Assessment
- Survival Analysis
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.